Glide Pharmaceutical Technologies Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Glide Pharmaceutical Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014025
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Glide Pharmaceutical Technologies Ltd (Glide Technologies), formerly Caretek Medical Ltd, is a clinical stage development company that concentrates on development and delivery of solid dose formulations of vaccines and therapeutics. Its technology portfolio includes Glide SDI, a solid dose injector system that is used for the injection of drugs and vaccines in solid doses. Glide Technologies’ pipeline of therapeutic products include octreotide; teriparatide; and exenatide, an agonist targeting type2 diabetes. The company’s pipeline of vaccine candidates includes anthrax vaccine and influenza vaccine. Glide Technologies is headquartered in Abingdon, the UK.

Glide Pharmaceutical Technologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Glide Pharmaceutical Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Glide Technologies Raises USD4 Million in Venture Financing 11
Glide Pharma Raises USD4 Million in Venture Financing 12
Glide Pharma Raises US$21.4 Million In Venture Financing 13
Partnerships 14
Glide Pharma Enters into Agreement with Cilian 14
Glide Pharmaceutical Enters Into Partnership Agreement with Nypro Healthcare 15
Glide Pharmaceutical Technologies Ltd – Key Competitors 16
Glide Pharmaceutical Technologies Ltd – Key Employees 17
Glide Pharmaceutical Technologies Ltd – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Glide Pharmaceutical Technologies Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Glide Pharmaceutical Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Glide Pharmaceutical Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Glide Technologies Raises USD4 Million in Venture Financing 11
Glide Pharma Raises USD4 Million in Venture Financing 12
Glide Pharma Raises US$21.4 Million In Venture Financing 13
Glide Pharma Enters into Agreement with Cilian 14
Glide Pharmaceutical Enters Into Partnership Agreement with Nypro Healthcare 15
Glide Pharmaceutical Technologies Ltd, Key Competitors 16
Glide Pharmaceutical Technologies Ltd, Key Employees 17

★海外企業調査レポート[Glide Pharmaceutical Technologies Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …
  • Pulmatrix Inc (PULM):企業の財務・戦略的SWOT分析
    Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that discovers and develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline products using its proprieta …
  • Ortho-Clinical Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Ortho-Clinical Diagnostics Inc (OCD) a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive soluti …
  • Lazard Ltd:戦略・SWOT・企業財務分析
    Lazard Ltd - Strategy, SWOT and Corporate Finance Report Summary Lazard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TD Ameritrade Holding Corporation:企業の戦略・SWOT・財務情報
    TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Novartis Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and gene therapy. It provides medicines such a …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Seabridge Gold Inc.:企業のM&A・事業提携・投資動向
    Seabridge Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seabridge Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Daiwa House Industry Co., Ltd. (1925):企業の財務・戦略的SWOT分析
    Daiwa House Industry Co., Ltd. (1925) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Manali Petrochemicals Ltd (MANALIPETC):企業の財務・戦略的SWOT分析
    Summary Manali Petrochemicals Ltd (MPL), a subsidiary of Southern Petrochemical Industries Corp Ltd, is a chemical company that develops and markets petrochemical products. The company offers products such as propylene oxide, propylene glycol, flexible and molded polyols, rigid polyols and elastomer …
  • Intelsat S.A. (I):企業の財務・戦略的SWOT分析
    Intelsat S.A. (I) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Croatia Airlines d.d.:企業の戦略・SWOT・財務情報
    Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tchibo GmbH (Foodservice):企業の戦略・SWOT・財務情報
    Tchibo GmbH (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Tchibo GmbH (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Andhra Bank (ANDHRABANK):企業の財務・戦略的SWOT分析
    Andhra Bank (ANDHRABANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Senhwa Biosciences Inc (6492)-製薬・医療分野:企業M&A・提携分析
    Summary Senhwa Biosciences Inc (Senhwa) is a drug development company that develops small molecule drugs for the treatment of cancer. The company’s products include CX-5461 and CX-4945. Its CX-5461 is a p53 activating Pol I inhibitor and anticancer compound for treating hematological malignancies. S …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆